{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:22:30Z","timestamp":1793226150242,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.heliyon.2025.e42594","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T11:29:26Z","timestamp":1739359766000},"page":"e42594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification and evaluation of bioactive compounds from Azadirachta indica as potential inhibitors of DENV-2 capsid protein: An integrative study utilizing network pharmacology, molecular docking, molecular dynamics simulations, and machine learning techniques"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7547-7431","authenticated-orcid":false,"given":"Md. Ahad Ali","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Nazmul Hasan","family":"Zilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahedi","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2025.e42594_bib1","first-page":"3","article-title":"Dengue\/dengue haemorrhagic fever: history and current status","volume":"vol. 277","author":"Gubler","year":"2006"},{"key":"10.1016\/j.heliyon.2025.e42594_bib2","series-title":"New Treat. Strateg. Dengue Other Flaviviral Dis.","first-page":"23","article-title":"Molecular biology of flaviviruses","author":"Harris","year":"2006"},{"key":"10.1016\/j.heliyon.2025.e42594_bib3","first-page":"1","article-title":"Natural vertical transmission of dengue virus in Aedes aegypti and Aedes albopictus: a systematic review","volume":"11","author":"Ferreira-de-Lima","year":"2018","journal-title":"Parasites \\& Vectors"},{"key":"10.1016\/j.heliyon.2025.e42594_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"others, the global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2025.e42594_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2149\/tmh.2011-S10","article-title":"Clinical manifestations and management of dengue\/DHF\/DSS","volume":"39","author":"Kalayanarooj","year":"2011","journal-title":"Trop. Med. Health"},{"key":"10.1016\/j.heliyon.2025.e42594_bib9","article-title":"Dengue in Bangladesh","volume":"1","author":"Bonna","year":"2023","journal-title":"IJID One Heal"},{"key":"10.1016\/j.heliyon.2025.e42594_bib10","year":"2024"},{"key":"10.1016\/j.heliyon.2025.e42594_bib12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-023-05790-6","article-title":"Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates","volume":"615","author":"Goethals","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2025.e42594_bib13","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1038\/s41586-021-04123-9","article-title":"Publisher Correction: a pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction","volume":"599","author":"Kaptein","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2025.e42594_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb2181","article-title":"NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models","volume":"13","author":"Moquin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.heliyon.2025.e42594_bib15","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1128\/JVI.05468-11","article-title":"Inhibition of dengue virus by targeting viral NS4B protein","volume":"85","author":"Xie","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.heliyon.2025.e42594_bib16","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1128\/JVI.00855-15","article-title":"Discovery of dengue virus NS4B inhibitors","volume":"89","author":"Wang","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.heliyon.2025.e42594_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2013.05.011","article-title":"Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication","volume":"99","author":"van Cleef","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.heliyon.2025.e42594_bib18","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.1371\/journal.pntd.0000785","article-title":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults","volume":"4","author":"Tricou","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.heliyon.2025.e42594_bib19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S1473-3099(14)70730-3","article-title":"others, Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"14","author":"Low","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.heliyon.2025.e42594_bib20","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/cid\/cis655","article-title":"others, Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial","volume":"55","author":"Tam","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2025.e42594_bib21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/cid\/civ949","article-title":"others, Lovastatin for the treatment of adult patients with dengue: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Whitehorn","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2025.e42594_bib22","doi-asserted-by":"crossref","first-page":"17992","DOI":"10.1073\/pnas.2003056117","article-title":"A cocrystal structure of dengue capsid protein in complex of inhibitor","volume":"117","author":"Xia","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2025.e42594_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2018.04.019","article-title":"Characterization and structure-activity relationship analysis of a class of antiviral compounds that directly bind dengue virus capsid protein and are incorporated into virions","volume":"155","author":"Smith","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.heliyon.2025.e42594_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108307","article-title":"A guide to the use of bioassays in exploration of natural resources","volume":"71","author":"Saboti\u010d","year":"2024","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.heliyon.2025.e42594_bib25","article-title":"Role of artificial intelligence in revolutionizing drug discovery","author":"Rehman","year":"2024","journal-title":"Fundam. Res."},{"key":"10.1016\/j.heliyon.2025.e42594_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104009","article-title":"How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons","volume":"29","author":"KP Jayatunga","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.heliyon.2025.e42594_bib27","article-title":"Advances in Artificial Intelligence (AI)-assisted approaches in drug screening","volume":"2","author":"Singh","year":"2024","journal-title":"Artif. Intell. Chem."},{"key":"10.1016\/j.heliyon.2025.e42594_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jmgm.2014.06.008","article-title":"Allosteric pocket of the dengue virus (serotype 2) NS2B\/NS3 protease: in silico ligand screening and molecular dynamics studies of inhibition","volume":"52","author":"Mukhametov","year":"2014","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.heliyon.2025.e42594_bib29","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1021\/acs.jpcb.4c05388","article-title":"Machine-learning approach to identify potential dengue virus protease inhibitors: a computational perspective","volume":"128","author":"Abduljalil","year":"2024","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.heliyon.2025.e42594_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1510029","article-title":"Machine learning and molecular docking prediction of potential inhibitors against dengue virus","volume":"12","author":"Hanson","year":"2024","journal-title":"Front. Chem."},{"key":"10.1016\/j.heliyon.2025.e42594_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12896-023-00815-4","article-title":"Target identification of small molecules: an overview of the current applications in drug discovery","volume":"23","author":"Tabana","year":"2023","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.heliyon.2025.e42594_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053535","article-title":"Identification of new protein interactions between dengue fever virus and its hosts, human and mosquito","volume":"8","author":"Mairiang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2025.e42594_bib33","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1073\/pnas.0305892101","article-title":"Solution structure of dengue virus capsid protein reveals another fold","volume":"101","author":"Ma","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2025.e42594_bib34","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1128\/JVI.77.12.7143-7149.2003","article-title":"Flavivirus capsid is a dimeric alpha-helical protein","volume":"77","author":"Jones","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.heliyon.2025.e42594_bib35","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2025.e42594_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024365","article-title":"Dengue virus capsid protein binds core histones and inhibits nucleosome formation in human liver cells","volume":"6","author":"Colpitts","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2025.e42594_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0378-8741(01)00395-6","article-title":"Inhibitory potential of neem (Azadirachta indica Juss) leaves on dengue virus type-2 replication","volume":"79","author":"Parida","year":"2002","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2025.e42594_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7382506","article-title":"Therapeutics role of Azadirachta indica (neem) and their active constituents in diseases prevention and treatment","volume":"2016","author":"Alzohairy","year":"2016","journal-title":"Evid. Based. Complement. Alternat. Med."},{"key":"10.1016\/j.heliyon.2025.e42594_bib39","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1055\/a-0608-4870","article-title":"Advantages of molecular Weight identification during Native MS screening","volume":"84","author":"Khan","year":"2018","journal-title":"Planta Med"},{"key":"10.1016\/j.heliyon.2025.e42594_bib40","doi-asserted-by":"crossref","first-page":"D588","DOI":"10.1093\/nar\/gku830","article-title":"VirusMentha: a new resource for virus-host protein interactions","volume":"43","author":"Calderone","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2025.e42594_bib41","doi-asserted-by":"crossref","first-page":"D583","DOI":"10.1093\/nar\/gku1121","article-title":"VirHostNet 2.0: surfing on the web of virus\/host molecular interactions data","volume":"43","author":"Guirimand","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.heliyon.2025.e42594_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/v10100519","article-title":"Viruses.STRING: a virus-host protein-protein interaction database","volume":"10","author":"Cook","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.heliyon.2025.e42594_bib43","first-page":"2016","article-title":"HPIDB 2.0: a curated database for host-pathogen interactions","author":"Ammari","year":"2016","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.heliyon.2025.e42594_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005879","article-title":"DenvInt: a database of protein-protein interactions between dengue virus and its hosts","volume":"11","author":"Dey","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.heliyon.2025.e42594_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004965","article-title":"DenHunt - a comprehensive database of the intricate network of dengue-human interactions","volume":"10","author":"Karyala","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.heliyon.2025.e42594_bib46","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.heliyon.2025.e42594_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.heliyon.2025.e42594_bib48","doi-asserted-by":"crossref","first-page":"D204","DOI":"10.1093\/nar\/gku989","article-title":"UniProt: a hub for protein information","volume":"43","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.heliyon.2025.e42594_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.heliyon.2025.e42594_bib50","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.heliyon.2025.e42594_bib51","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1517\/17460441.2010.524924","article-title":"Exploiting PubChem for virtual screening","volume":"5","author":"Xie","year":"2010","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.heliyon.2025.e42594_bib52","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.heliyon.2025.e42594_bib53","doi-asserted-by":"crossref","first-page":"W375","DOI":"10.1093\/nar\/gkm216","article-title":"others, MolProbity: all-atom contacts and structure validation for proteins and nucleic acids","volume":"35","author":"Davis","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.heliyon.2025.e42594_bib54","first-page":"35","article-title":"Physicochemical, Functional and structural characterization of wheat germin using in silico methods","volume":"3","author":"Hooda","year":"2011","journal-title":"Curr. Res. J. Biol. Sci."},{"key":"10.1016\/j.heliyon.2025.e42594_bib55","doi-asserted-by":"crossref","DOI":"10.1177\/11779322221149616","article-title":"In silico structure prediction, molecular docking, and dynamic simulation of Plasmodium falciparum AP2-I transcription factor","volume":"17","author":"Oladejo","year":"2023","journal-title":"Bioinform. Biol. Insights"},{"key":"10.1016\/j.heliyon.2025.e42594_bib56","series-title":"Discovery Studio Visualizer v21.1.0.20298","author":"Biovia","year":"2021"},{"key":"10.1016\/j.heliyon.2025.e42594_bib57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/pro.3934","article-title":"The AutoDock suite at 30","volume":"30","author":"Goodsell","year":"2021","journal-title":"Protein Sci"},{"key":"10.1016\/j.heliyon.2025.e42594_bib58","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1021\/ci100385n","article-title":"Software review of ChemBioDraw 12.0","volume":"50","author":"Milne","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.heliyon.2025.e42594_bib59","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/ja00467a001","article-title":"Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms","volume":"99","author":"Allinger","year":"1977","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.heliyon.2025.e42594_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004586","article-title":"AutoDockFR: advances in protein-ligand docking with explicitly specified binding site flexibility","volume":"11","author":"Ravindranath","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.heliyon.2025.e42594_bib61","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1093\/bioinformatics\/btw367","article-title":"AutoSite: an automated approach for pseudo-ligands prediction-from ligand-binding sites identification to predicting key ligand atoms","volume":"32","author":"Ravindranath","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.heliyon.2025.e42594_bib62","article-title":"Breaking down resistance: verapamil analogues augment the efficacy of antibiotics against Streptococcus pneumoniae via MATE transporter interference, Informatics Med","volume":"47","author":"Ahmed","year":"2024","journal-title":"Unlocked"},{"key":"10.1016\/j.heliyon.2025.e42594_bib63","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.heliyon.2025.e42594_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2025.e42594_bib65","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"V Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2025.e42594_bib66","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.heliyon.2025.e42594_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ph16121662","article-title":"Quality assessment of selected protein structures derived from homology modeling and AlphaFold","volume":"16","author":"Binbay","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.heliyon.2025.e42594_bib68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.12688\/f1000research.2-211.v1","article-title":"Protein structure quality assessment based on the distance profiles of consecutive backbone C\u03b1 atoms","volume":"2","author":"Chakraborty","year":"2013","journal-title":"F1000Research"},{"key":"10.1016\/j.heliyon.2025.e42594_bib69","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1007\/s00044-023-03132-9","article-title":"Synthesis, in-silico based virtual screening,anti-cancer potential of novel1,2,3-triazole-thiadiazole hybrid derivatives as Aurora kinase A (ARK-A) and Extracellular regulated kinase 2 (ERK2) dual inhibitors","volume":"32","author":"Bontha","year":"2023","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.heliyon.2025.e42594_bib70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1741-7007-9-71","article-title":"Molecular dynamics simulations and drug discovery","volume":"9","author":"Durrant","year":"2011","journal-title":"BMC Biol."},{"key":"10.1016\/j.heliyon.2025.e42594_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2022.101046","article-title":"Novel compounds from endophytic fungi of Ceriops decandra inhibit breast cancer cell growth through estrogen receptor alpha in in-silico study","volume":"32","author":"Munshi","year":"2022","journal-title":"Informatics Med. Unlocked"},{"key":"10.1016\/j.heliyon.2025.e42594_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1501240","article-title":"Regulation of protein-ligand binding affinity by hydrogen bond pairing","volume":"2","author":"Chen","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.heliyon.2025.e42594_bib73","doi-asserted-by":"crossref","first-page":"37707","DOI":"10.1039\/D0RA06379G","article-title":"Ilimaquinone (marine sponge metabolite) as a novel inhibitor of SARS-CoV-2 key target proteins in comparison with suggested COVID-19 drugs: designing, docking and molecular dynamics simulation study","volume":"10","author":"Surti","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.heliyon.2025.e42594_bib74","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1080\/07391102.2018.1521748","article-title":"In silico insights on tankyrase protein: a potential target for colorectal cancer","volume":"37","author":"Loganathan","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.heliyon.2025.e42594_bib75","article-title":"Identification of antidiabetic inhibitors from Allophylus villosus and Mycetia sinensis by targeting \u03b1-glucosidase and PPAR-\u03b3: in-vitro, in-vivo, and computational evidence","volume":"32","author":"Nur Kabidul Azam","year":"2024","journal-title":"Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc."},{"key":"10.1016\/j.heliyon.2025.e42594_bib76","article-title":"Profiling of secondary metabolite and evaluation of anti-diabetic potency of Crotalaria quinquefolia (L): in-vitro, in-vivo, and in-silico approaches","volume":"32","author":"Nahar","year":"2024","journal-title":"Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc."},{"key":"10.1016\/j.heliyon.2025.e42594_bib77","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/js9804011","article-title":"Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption","volume":"88","author":"Clark","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.heliyon.2025.e42594_bib78","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.heliyon.2025.e42594_bib79","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2025.e42594_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15112523","article-title":"Caco-2 cell line standardization with pharmaceutical requirements and in vitro model suitability for permeability assays","volume":"15","author":"Kus","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2025.e42594_bib81","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0021-9258(19)75806-2","article-title":"The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation","volume":"262","author":"Ueda","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2025.e42594_bib82","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","article-title":"Role of P-glycoprotein in pharmacokinetics","volume":"42","author":"Lin","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.heliyon.2025.e42594_bib83","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.drudis.2011.10.023","article-title":"Toward in silico structure-based ADMET prediction in drug discovery","volume":"17","author":"Moroy","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.heliyon.2025.e42594_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/srep46277","article-title":"Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors","volume":"7","author":"Lagorce","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2025.e42594_bib85","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.apsb.2018.04.003","article-title":"Drug metabolism in drug discovery and development","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.heliyon.2025.e42594_bib86","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/019262339502300203","article-title":"Basic principles of pharmacokinetics","volume":"23","author":"Benet","year":"1995","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.heliyon.2025.e42594_bib87","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1208\/s12248-013-9465-7","article-title":"Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney","volume":"15","author":"Motohashi","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.heliyon.2025.e42594_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012149","article-title":"Discovery of novel HIV protease inhibitors using modern computational techniques","volume":"23","author":"Okafor","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2025.e42594_bib89","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1025361621494","article-title":"In silico prediction of drug toxicity","volume":"17","author":"Dearden","year":"2003","journal-title":"J. Comput. Aided. Mol. Des."},{"key":"10.1016\/j.heliyon.2025.e42594_bib90","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1021\/acsomega.0c01581","article-title":"In silico ADME\/tox profiling of natural products: a focus on BIOFACQUIM","volume":"5","author":"Dur\u00e1n-Iturbide","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.heliyon.2025.e42594_bib91","series-title":"Maximum Tolerated Dose","first-page":"43","author":"Gad","year":"2024"},{"key":"10.1016\/j.heliyon.2025.e42594_bib92","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/bimj.201600084","article-title":"Dose-finding methods for Phase I clinical trials using pharmacokinetics in small populations","volume":"59","author":"Ursino","year":"2017","journal-title":"Biom. J."},{"key":"10.1016\/j.heliyon.2025.e42594_bib93","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4161\/chan.2.2.6004","article-title":"Role of hERG potassium channel assays in drug development","volume":"2","author":"Priest","year":"2008","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.heliyon.2025.e42594_bib94","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.addr.2015.03.003","article-title":"Computational investigations of hERG channel blockers: new insights and current predictive models","volume":"86","author":"Villoutreix","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2025.e42594_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20163870","article-title":"Structural and functional properties of the capsid protein of dengue and related flavivirus","volume":"20","author":"Faustino","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2025.e42594_bib96","doi-asserted-by":"crossref","DOI":"10.1177\/2040206618761299","article-title":"Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses","volume":"26","author":"Eyer","year":"2018","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.heliyon.2025.e42594_bib97","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/pathogens11030293","article-title":"Antiviral agents against flavivirus protease: prospect and future direction","volume":"11","author":"Samrat","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.heliyon.2025.e42594_bib98","series-title":"Virus Entry Inhib. Stopping Enemy Gate","first-page":"171","article-title":"Flavivirus entry inhibitors","author":"Yu","year":"2022"},{"key":"10.1016\/j.heliyon.2025.e42594_bib99","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/j.apsb.2024.03.002","article-title":"In silico off-target profiling for enhanced drug safety assessment","volume":"14","author":"Liu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.heliyon.2025.e42594_bib100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.01429-12","article-title":"A novel inhibitor of dengue virus replication that targets the capsid protein","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.heliyon.2025.e42594_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.chphi.2024.100784","article-title":"Discovering the therapeutic potential of Naringenin in diabetes related to GLUT-4 and its regulatory factors: a computational approach","volume":"10","author":"Khakpour","year":"2025","journal-title":"Chem. Phys. Impact"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844025009740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844025009740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:33:29Z","timestamp":1784068409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844025009740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2405844025009740"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42594","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and evaluation of bioactive compounds from Azadirachta indica as potential inhibitors of DENV-2 capsid protein: An integrative study utilizing network pharmacology, molecular docking, molecular dynamics simulations, and machine learning techniques","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e42594"}}